GeneDx Holdings Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-77.81	-21.02	-52.29	-175.77	-548.98	-245.39
Depreciation & Amortization	26.36	25.22	21.95	33.73	59.31	21.81
Stock-Based Compensation	37.18	32.16	9.14	-0.33	41.98	41.98
Other Adjustments	41.9	12.51	17.44	0.45	94.66	-194.35
Change in Receivables	-30.23	-36.23	-5.18	10.53	5.53	5.54
Changes in Inventories	0.29	-3.44	-2.59	0.98	2.35	-10.62
Changes in Accounts Payable	-11.89	12.1	-20.52	-49.17	34.46	25.92
Changes in Unearned Revenue	-	-	-	-	-	-1.31
Changes in Other Operating Activities	-0.27	11.97	3.54	-0.58	-8.46	-11.44
Operating Cash Flow	-9.31	33.28	-28.5	-180.15	-319.16	-190.43
Capital Expenditures	-19.34	-19.02	-5.49	-5.25	-7.16	-9.4
Sale of Property, Plant & Equipment	-	-	-	4.03	-	-
Purchases of Intangible Assets	-	-	-	-0.46	-7.17	-11.39
Purchases of Investments	-2.97	-	-66.3	-47.67	-	-
Proceeds from Sale of Investments	38.54	46.03	41.66	17.77	-	-
Payments for Business Acquisitions	-16.26	-32.86	-	-67.82	-127	-
Investing Cash Flow	-69.36	-61.52	-30.13	-43.73	-141.33	-20.79
Long-Term Debt Issued	129.81	46.7	46.5	191.55	-	-
Long-Term Debt Repaid	-59.36	-1.21	-0.5	-2	-	-9.74
Net Long-Term Debt Issued (Repaid)	70.45	45.49	46	189.55	-	-9.74
Issuance of Common Stock	133.96	51.69	47.39	143.29	200.61	793.96
Repurchase of Common Stock	-	-	-	-	-	-230.67
Net Common Stock Issued (Repurchased)	133.96	51.69	47.39	143.29	200.61	563.29
Other Financing Activities	-2.34	-2.45	-2.73	-3.6	-3.29	-59.82
Financing Cash Flow	72.9	48.03	44.16	186.24	197.32	493.73
Net Cash Flow	-5.78	19.79	-14.47	-37.64	-263.17	282.51

SEC Filings: 10-K · 10-Q